Advertisement

Stentimplantation: selbstexpandierbare Stentgrafts

  • G. Krupski-Berdien

Zusammenfassung

Endovaskuläre selbstexpandierbare Stentgrafts können neben der klassischen Indikation der Aneurysma-Ausschaltung und Überdeckung von Gefäßlazerationen mit Blutung auch zur Behandlung einer arteriellen Verschlusskrankheit im iliakalen und femoropoplitealen Stromgebiet eingesetzt werden. Nach Einführung moderner Stents und der medikamentenfreisetzenden Ballons ist der Stentgraft Methode der 2. Wahl in der primären Therapie und bei der In-Stent-Restenose. Der Stentgraft kann bei akuten Verschlüssen, insbesondere bei koinzidentem (v. a. Popliteal-) Aneurysma, primär anstelle oder in Kombination mit einer Lysetherapie eingesetzt werden. Die Edge-Stenose ist die wichtigste die Offenheitsrate beeinflussende Komplikation und bedarf besonderer Beachtung. Bei der Implantation gilt es, auf eine exakte Dimensionierung und die Einhaltung von Hygieneregeln zu achten.

Literatur

  1. Al Shammeri O, Bitar F, GhitelmanJ, Soukas PA (2012) Viabahn for femoropopliteal in-stent restenosis. Ann Saudi Med 32 (6): 572–582CrossRefGoogle Scholar
  2. Alimi YS, Hakam Z, Hartung O, et al. (2008) Efficacy of Viabahn in the treatment of severe superficial femoral artery lesions: which factors influence long-term patency? Eur J Vasc Endovasc Surg 35:346–352CrossRefPubMedGoogle Scholar
  3. Balko A, Piasecki GJ, Shah DM, et al. (1986) Transluminal placement of intraluminal polyurethane prosthesis for abdominal aortic aneurysm. J Surg Res 40:305–9Google Scholar
  4. Bekken JA, Hidde J, de Vires J-P JM, Fioole B (2014) Self-expanding stents and aortoiliac occlusive disease: a review of the literature. Med. Devics (Aukl) 7: 99–105Google Scholar
  5. Bishu K, Armstrong EJ (2015) Supera® self expanding stents for endovascular treatment of femoropopliteal diease. Vascular Health and Risk Management 11: 387–395Google Scholar
  6. Bleyn J, Schol F, Vanhandenhove I, Vercaeren P, Marien C (2004) Endovascular reconstruction of the superficial femoralartery. In: Becquemin JP, Alimi YS, Watelet J, Loisance D (eds) Controversies and Updates in Vasc Card Surg. Torino, Italy. Edizioni Minerva Medica 14:87–91Google Scholar
  7. Bosiers M, Iyer V, Deloose K, Verbist J, Peeters (2007) Femish experince using Advanta V12 stent-graft for the treatment of iliac artery occlusive disease. J Cadiovasc Surg (Torino) 48(1): 7–12Google Scholar
  8. Chang RW, Goodney PP, Baek JH, Nolan BW, Rzucidlo EM, Powell RJ (2008) Log-term results of combined common femoral endatherectomy and iliac stenting/stent grafting for occlusive disease. J Vasc Surg 48(2): 362–367CrossRefPubMedGoogle Scholar
  9. Dorigo W, Pulli R, Castelli P, Dorrucci V, Ferilli F, De Blasis G, et al. (2011) A multicenter comparison between autologous saphenous vein and heparin-bonded expanded polytetrafluoroethylene (ePTFE) graft in the treatment of critical limb ischemia in diabetics. J Vasc Surg 54(5):1332–8CrossRefPubMedGoogle Scholar
  10. Farraj N, Srivastava A, Pershad A (2009) One-year outcomes for recanalization of long superficial femoral artery chronic total occlusions with the Viabahn stent graft. J Inv Card 21(6):278–281Google Scholar
  11. Fischer M, Schwabe C, Schulte KL (2006) Value of the Hemobahn/Viabahn Endoprosthesis in the treatment of long chronic lesions of the superficial femoral artery: 6 years of experience. J Endovasc Ther 13:281–290CrossRefPubMedGoogle Scholar
  12. Geraghty PJ, Mewissen MW, Jaff MR, Ansel GM; VIBRANT Investigators (2013) Three-year results of the VIBRANT trial of VIABAHN endoprosthesis vs bare nitinol stent implantation for complex superficial femoral artery occlusive disease. Journal of Vascular Surgery 58(2):386–395Google Scholar
  13. Giles H, Lesar C, Erdoes L, Sprouse R, Myers S (2008) Ballon-expandable covered stent therapy of complex endovascular pathology. Ann Vasc Surg 22(6): 762–768CrossRefPubMedGoogle Scholar
  14. Golchehr B, Holewijn S, Kruse RR, van Walraven LA, Zeebregts CJ, Reijnen MM (2015) Efficacy of treatment of edge stenosis of endografts inserted for superficial femoral artery stenotic disease. Catheter Cardiovasc Interv 86(3): 492–8CrossRefPubMedGoogle Scholar
  15. Gore Viabahn (2009) Interim 1-year VIBRANT results presented for Gore Viabahn in SFA treatment. Endovascular Today website. http://bmctoday.net/evtoday/2009/10/article.asp?f=eNews102909_05.htm
  16. Hendriks JM, van Dijk LC, van Sambeek MRHM (2006) Indications for endovascular abdominal aortic aneurysms treatment. Interventional Cardiology 1(1):63–64Google Scholar
  17. Heyligers JMM, Lisman T, Verhagen HJM, Weeterings C, de Groot PG, Moll FL (2008) A heparin-bonded vascular graft generates no systemic effect on markers of hemostasis activation or detectable heparin-induced thrombocytopenia–associated antibodies in humans. Journal of Vascular Surgery47(2):324–329CrossRefPubMedGoogle Scholar
  18. Ichihashi S, Higashiura W, Itoh H, Sakaguchi S, Nishimine K, Kichikawa K (2011) Long-term outcomes for systemic primary stent palcement in complex iliac artery occlusive disease classified according to TASC concensus. J Vasc Surg 53(4): 992–999Google Scholar
  19. Jahnke T, Andresen R, Müller-Hülsbeck S, et al. (2003) Hemobahn stent-grafts for treatment of femoropopliteal arterial obstructions: midterm results of a prospective trial. Journal of Vascular & Interventional Radiology 14(1):41–51CrossRefPubMedGoogle Scholar
  20. Jebran AF, Popov AF, Zenker D, Bireta C, Friedrich M, Danner BC, Bougioukas I, Schoendube FA, Stojanovic T (2013) Is there an alternative to the surgical above-knee bypass in treatment of superficial femoral artery disease? Experiences with Viabahnstent graft. Vasc Endovasc Surg 47(7):502–6CrossRefPubMedGoogle Scholar
  21. Kougias P, Chen A, Cagiannos C, Bechara CF, Huynh TT, Lin PH (2009) Subintimal placement of covered stent versus subintimal balloon angioplasty in the treatment of long-segment superficial femoral artery occlusion. Am J Surg 198(5): 645–649CrossRefPubMedGoogle Scholar
  22. Krupski-Berdien G, Wenk H, Königstein R, Koshty A, Reichert V, Schmitz-Rixen T, Stojanovic T, Mahnken AH (2015) Endovascular stentgraft based treatment of femoropopliteal peripheral artery disease: results from the literature versus real life experience, IROS, 2602.4Google Scholar
  23. Lammer J, Dake MD, Bleyn J, et al. (2000) Peripheral arterial obstruction: prospective study of treatment with a transluminally placed self-expanding stent graft. Radiology 217(1):95–104CrossRefPubMedGoogle Scholar
  24. Lammer J, Zeller T, Hausegger KA, et al. (2013) Heparin-bonded covered stents versus bare metal stents for complex femoro-popliteal artery lesions: the randomized VIASTAR trial. Journal of the American College of Cardiology 62(15):1320–1327CrossRefPubMedGoogle Scholar
  25. Lazarus HM (1988) Intraluminal graft device, system and method. US patent 4:787,899Google Scholar
  26. Lensvelt MM, Wikkeling OR, Oostayen JA, Roukema JG, Zeebregts CJ, Reijnen MM (2012) The use of endografts to create an endoluminal femoropopliteal bypass after failed above-knee femoropopliteal open bypass surgery. Vascular & Endovascular Surgery46(4):338–341CrossRefPubMedGoogle Scholar
  27. Marin ML, Veith FJ, Cynamon J (1996) Effect of polytretrafluoroethylene covering of Palmaz Stents on the development of intimal hyperplasia in human iliac arteries. J VAsc Interv Radiol 7(5): 651–65CrossRefPubMedGoogle Scholar
  28. McQuade K, Gable D, Pearl G, Theune B, Black S (2010) Four-year randomized prospective comparison of percutaneous ePTFE/nitinol self-expanding stent graft versus prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease. Journal of Vascular Surgery 52(3):584–591CrossRefGoogle Scholar
  29. Mwipatayi BP, Thomas S, Wong J, Temple SE, Vijayan V, Jackson M, Burrows SA; Covered Versus Balloon Expandable Stent Trial (COBEST) Co-investigators (2011) A comparison of covered vs bare expandable stents for the treatment of aortoiliac occlusive disease Journal of Vascular Surgery 54(6):1561–70Google Scholar
  30. Rabellino M, Zander T, Baldi S, et al. (2009) Clinical follow-up in endovascular treatment for TASC C-D lesions in femoro-popliteal segment. Cath Cardiovasc Interv 73(5):701–705CrossRefPubMedGoogle Scholar
  31. Saxon RR, Chervu A, Jones PA, et al. (2013) Heparin-bonded, expanded polytetrafluoroethylene-lined stent graft in the treatment of femoropopliteal artery disease: 1-year results of the VIPER (Viabahn Endoprosthesis with Heparin Bioactive Surface in the Treatment of Superficial Femoral Artery Obstructive Disease) Trial. Journal of Vascular & Interventional Radiology24(2):165–173CrossRefPubMedGoogle Scholar
  32. Saxon RR, Coffman JM, Gooding JM, Ponec DJ (2007) Long-term patency and clinical outcome of the Viabahn Stent-Graft for femoropopliteal artery obstructions. J Vasc Interv Radiol 18:1341–1350CrossRefPubMedGoogle Scholar
  33. Saxon RR, Dake MD, Volgelzang RL, Katzen BT, Becker GJ (2008) Randomized, multicenter study comparing expanded polytetrafluoroethylene-covered endoprosthesis placement with percutaneous transluminal angioplasty in the treatment of superficial femoral artery occlusive disease. J Vasc Interv Radiol 19:823–832CrossRefPubMedGoogle Scholar
  34. Schmidt A, Piorkowski M, Görner H, Steiner S, Bausback Y, Scheinert S, Banning-Eichenseer, Staab H, Branzen D, Varcoe RL, Scheinert D (2016) Drug-coated Ballons for complex femoropopliteal lesions: 2 year results of a real world registry. JACC Cardiovasc Interv 9(7): 715–724Google Scholar
  35. Schneider JR, Pantel NH, HashemiF, KimS, Verta MJ (2011) Infected viabahnstentgraft in the superficial femoral artery. Eur J Endovasc Surg 42(5): 699–703CrossRefPubMedGoogle Scholar
  36. Tielliu IF, et al. (2007) Endovascular treatment of popliteal artery aneurysms: is the technique a valid alternative to open surgery? J Cardiovasc Surg (Torino) 48(3): 275–9Google Scholar
  37. Treitl M, Rademacher A, Becker-Lienau J, Reiser MF, Hoffmann U, Czihal M (2011) Cardiovasc Interv Radiol 34(3): 642–646Google Scholar
  38. Volodos NL, Shekhanin VE, Karpovich IP, et al. (1986) A self-fixing synthetic blood vessel endoprosthesis (in Russian). Vestn Khir Im I I Grek 137:123–5Google Scholar
  39. White GH, Yu W, May J, Stephen MS, Waugh RC (1994) A new nonstented balloon-expandable graft for straight or bifurcated endoluminal bypass. J Endovasc Surg 1:16–24Google Scholar
  40. Zeller T, Rastan A, Macharzina R, Beschorner U, Noory E (2015) Novel approach to the management of andvanced artery disease: perspectives on drug-coated balloons drug eluting stents, and bioabsorbable scaffolds. Curr Card Rep 17(9): 624Google Scholar
  41. Zhao HQ, Nikanorov A, Virmani R, Jones R, Pacheco E, Schwarzt LB (2009) Late stent expansion and neointimal proligeration of oversized nitinol stents in peripheral arteries. Cardiovasc Interv Radiol 32(4): 720–726CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Deutschland 2018

Authors and Affiliations

  1. 1.Diagnostische und interventionelle RadiologieKrankenhaus Reinbeck St. Adolf StiftReinbekDeutschland

Personalised recommendations